Clinical Trials in China / NCT07288346
Recruiting
Not applicable
Effect of Predictive Model on Double-Balloon Enteroscopy
NCT07288346 · tracked via the Priya Life Science China tracker
Condition(s) studied
Double-balloon Enteroscopy
Investigational drug(s) / intervention(s)
Predictive model
Predictive model: Endoscopists obtain the patient's predictive model scores before double-balloon enteroscopy.
Study summary
The aim of this study is to assess the effect of predictive model on total enteroscopy rate in double-balloon enteroscopy.
Eligibility
Inclusion Criteria:
1. patients aged between 18 and 80 years who were planned to undergo an attempt at total enteroscopy for suspected small-bowel disease
2. CT scan of the abdomen was performed within two weeks before enteroscopy
Exclusion Criteria:
1. cases terminated upon the target lesion (strictures, masses, hemorrhagic or other lesions) and not the maximal insertion
2. poor quality of bowel preparation
3. high risk esophageal varices
4. the insertion route is not oral or anal because of changes in anatomical structure
5. unsuitable for general anesthesia
6. pregnant women
7. unable to provide informed consent
Primary outcome measure(s)
- Total enteroscopy rate — 8 months
Total enteroscopy rate was defined as the number of patients with complete visualization of the small bowel divided by the total number of patients.
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Dezhou People's Hospital | Dezhou | Shandong | Recruiting |
| Qilu Hospital of Shandong University (Qingdao) | Qingdao | Shandong | Recruiting |
| Yantai Affiliated Hospital of Binzhou Medical University | Yantai | Shandong | Recruiting |
| Zaozhuang Municipal Hospital | Zaozhuang | Shandong | Recruiting |
| Qilu Hospital of Shandong University | Jinan | Shangdong | Recruiting |
More Shandong University trials in China
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07288346 on ClinicalTrials.gov ↗ ← All trials in China